Researchers have found that a molecule known as CRSBP-1 ligands binds to a receptor on the surface of lymphatic vessels, acting like the token to gain entry into the lymphatic vessel network.
Researchers have found that a molecule known as CRSBP-1 ligands binds to a receptor on the surface of lymphatic vessels, acting like the token to gain entry into the lymphatic vessel network.